These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6796778)

  • 1. Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies.
    Batshaw ML; Brusilow SW
    J Inherit Metab Dis; 1981; 4(4):231. PubMed ID: 6796778
    [No Abstract]   [Full Text] [Related]  

  • 2. Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia.
    Praphanphoj V; Boyadjiev SA; Waber LJ; Brusilow SW; Geraghty MT
    J Inherit Metab Dis; 2000 Mar; 23(2):129-36. PubMed ID: 10801054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of urea cycle disorders.
    Batshaw ML; Monahan PS
    Enzyme; 1987; 38(1-4):242-50. PubMed ID: 3326732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance.
    Simell O; Sipilä I; Rajantie J; Valle DL; Brusilow SW
    Pediatr Res; 1986 Nov; 20(11):1117-21. PubMed ID: 3099249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
    Enns GM; Berry SA; Berry GT; Rhead WJ; Brusilow SW; Hamosh A
    N Engl J Med; 2007 May; 356(22):2282-92. PubMed ID: 17538087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.
    Barshop BA; Breuer J; Holm J; Leslie J; Nyhan WL
    J Inherit Metab Dis; 1989; 12(1):72-9. PubMed ID: 2501586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On combination therapy with benzoate and piridoxilate.
    Cyr DM; Tremblay GC
    Am J Dis Child; 1989 Dec; 143(12):1392. PubMed ID: 2589268
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternative pathway therapy for urea cycle disorders.
    Feillet F; Leonard JV
    J Inherit Metab Dis; 1998; 21 Suppl 1():101-11. PubMed ID: 9686348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse.
    Batshaw ML; Hyman SL; Coyle JT; Robinson MB; Qureshi IA; Mellits ED; Quaskey S
    Pediatr Res; 1988 Apr; 23(4):368-74. PubMed ID: 3374991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion.
    Brusilow SW
    Pediatr Res; 1991 Feb; 29(2):147-50. PubMed ID: 2014149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of urinary carnitine profile induced by benzoate administration.
    Sakuma T
    Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium benzoate and arginine: alternative pathway therapy in inborn errors of urea synthesis.
    Batshaw ML
    Prog Clin Biol Res; 1983; 127():69-83. PubMed ID: 6889404
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective management of a child with neonatal citrullinemia.
    Melnyk AR; Matalon R; Henry BW; Zeller WP; Lange C
    J Pediatr; 1993 Jan; 122(1):96-8. PubMed ID: 8419623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypocarnitinemia in patients affected by a primary defect of ammonia metabolism treated with sodium benzoate].
    Michalak A; Lambert MA; Dallaire L; Melançon SB; Laframboise R; Lemieux B; Qureshi IA
    Diabete Metab; 1990; 16(3):226-33. PubMed ID: 2210018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzoylalanine: detection and identification of an alanine conjugate with benzoic acid in hyperammonemic patients treated with sodium benzoate.
    Shinka T; Inoue Y; Kuhara T; Matsumoto M; Matsumoto I
    Clin Chim Acta; 1985 Oct; 151(3):293-300. PubMed ID: 4053389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle.
    Lee B; Yu H; Jahoor F; O'Brien W; Beaudet AL; Reeds P
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8021-6. PubMed ID: 10869432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
    Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
    N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of 10% sodium benzoate plus 10% sodium phenylacetate with various flavored vehicles.
    Gutteridge C; Kuhn RJ
    Am J Hosp Pharm; 1994 Oct; 51(19):2508, 2510. PubMed ID: 7847413
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic sodium benzoate therapy in children with inborn errors of urea synthesis: effect on carnitine metabolism and ammonia nitrogen removal.
    Feoli-Fonseca JC; Lambert M; Mitchell G; Melançon SB; Dallaire L; Millington DS; Qureshi IA
    Biochem Mol Med; 1996 Feb; 57(1):31-6. PubMed ID: 8812724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.
    Kubota K; Ishizaki T
    Eur J Clin Pharmacol; 1993; 45(5):465-8. PubMed ID: 8112377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.